Results 91 to 100 of about 10,851 (230)

Comparison between the efficacy of cysteamine cream and combined hydroquinone cream in the treatment of melasma using skin analytical systems: An open-label quasi-randomized controlled trial in Asia patients

open access: yesDermatologica Sinica
Background: The mainstay of treatment for melasma is topical hydroquinone or preparations containing hydroquinone. In recent years, cysteamine cream has gained popularity in the treatment of hyperpigmentation disorders.
Andy Deng-Chi Chuang   +6 more
doaj   +1 more source

Synthesis of 1,2,5,7-dithiadiazonan-6-ylidenecyanamide. A New Potential Cysteamine Derivate Radioprotector Compound [PDF]

open access: gold, 2007
Enrique Ángeles   +8 more
openalex   +1 more source

Radioprotective Efficacy of Cysteamine [PDF]

open access: yesActa Radiologica: Therapy, Physics, Biology, 1964
A, BOSE, S, BOSE, P, DE
openaire   +2 more sources

Targeting Melasma: Innovations in Pigment Deposition and Photoaging in Cosmetic Dermatology

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background Melasma is a chronic, relapsing hyperpigmentation disorder driven by complex interactions among genetic predisposition, hormonal fluctuations, UV exposure, oxidative stress, inflammation, and photoaging. Its psychosocial impact is substantial, especially among women with darker skin types, and treatment remains challenging due to ...
Ting Liao   +4 more
wiley   +1 more source

The Use of Tranexamic Acid to Treat Melasma: A Systematic Review and Meta‐Analysis

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Introduction Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine that inhibits bleeding due to its effects on plasminogen conversion, approved by the FDA to treat menorrhagia and prevent bleeding in hemophilia patients undergoing dental extraction.
Nabila Scabine Pessotti   +7 more
wiley   +1 more source

Improving the prognosis of nephropathic cystinosis

open access: yesInternational Journal of Nephrology and Renovascular Disease, 2014
Martine TP Besouw,1,2 Elena N Levtchenko1,21Department of Pediatric Nephrology, University Hospitals Leuven, Belgium; 2Laboratory of Pediatrics, Catholic University Leuven, Leuven, BelgiumAbstract: Cystinosis is an autosomal recessive inherited lysosomal
Besouw MTP, Levtchenko EN
doaj  

Electrochemical Studies of Ochratoxin A Mycotoxin at Gold Electrodes Modified with Cysteamine Self‐Assembled Monolayers. Its Ultrasensitive Quantification in Red Wine Samples [PDF]

open access: bronze, 2011
Patricio René Perrotta   +6 more
openalex   +1 more source

Therapeutic strategies in cystinosis: A focus on cysteamine and beyond

open access: yesExperimental and Molecular Pathology
Cystinosis is a autosomal recessive lysosomal storage disorder caused by mutations in the CTNS gene, which encodes cystinosin, a cystine transporter.
Angelo Santoro   +2 more
doaj   +1 more source

Mitigative role of cysteamine against unilateral renal reperfusion injury in Wistar rats

open access: yesFrontiers in Pharmacology
BackgroundIschemia-reperfusion injury (IRI) is unavoidable during kidney transplant and it is responsible for delayed or non-function after kidney transplantation. Cysteamine is the standard drug in the management of nephropathic cystinosis and its extra-
Babatunde Adebola Alabi   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy